Biopharma | June 29, 2025
Sartorius expands manufacturing and R&D capacities for bioprocess solutions in France
Extended lab space for product development, customer demos, and training
Extended lab space for product development, customer demos, and training
Changhua site meets international regulatory standards for global medical applications
TEMPLE, a Phase 3 multicenter, randomized, double-blind, head-to-head study, evaluated the tolerability, safety and efficacy of atogepant compared to topiramate for the preventive treatment of migraine in adult patients with a history of four or more migraine days per month
Innovative agents highlight growth of targeted protein degradation platform and BMS' leadership in innovative cancer therapies
Enflosina is a long-acting monoclonal antibody that provides direct protection for up to 5 months
Bisoprolol is a highly cardioselective beta-1 adrenergic blocker used to manage high blood pressure,
The 16,000-square-foot expansion enhances DuPont’s global sterile operations
The NPPA has capped prices for 41 drug combinations including diabetes, cholesterol, and sleep disorder treatments
The trial targets MCAS/MCAD, an under-recognized, debilitating condition with an unknown cause and no cure
Approximately 35% of male cancer patients and 12% of female cancer patients at Paras Health were diagnosed with tobacco-related cancers
Subscribe To Our Newsletter & Stay Updated
